AGP Picks
View all

World of Culture Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World of Culture Times.

Press releases published on May 26, 2026

Vanderbilt Report: SecureTech Innovations Inc Swings From Stockholder Deficit to $10.6M Equity and First-Ever Profit — NASDAQ Uplisting Targeted Q2 2026
Nu-Tek BioSciences Fuels Animal-Free Raw Materials Revolution, Joins Minnesota Pavilion #4507 at BIO 2026
Nu-Tek BioSciences treibt die Revolution im Bereich tierfreier Rohstoffe voran, Teil des Minnesota Pavilion #4507 auf der BIO 2026
Nu-Tek BioSciences accélère la révolution des matières premières sans origine animale et rejoint le pavillon du Minnesota #4507 au salon BIO 2026
MBX Biosciences to Present at the Jefferies 2026 Global Healthcare Conference in New York City
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
LENZ Therapeutics to Participate in Upcoming Investor Conferences
After 7 Million Investigations in Production, 7AI Widens the Gap in Agentic Security with PLAID ELITE and 100 New AI Jobs in Boston
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
Black Rock Coffee Bar Announces Participation in Upcoming Investor Conferences
Peptide Therapy Websites Tout Benefits Nearly 4x More Often Than Safety Details, 100-Page Audit Finds
Gentherm Named a 2025 Supplier of the Year by General Motors
Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026
Postal Realty Trust to Present at Nareit’s REITweek 2026
VenHub Extends Flagship Smart Store Partnership at LAX/Metro Transit Center for Additional Two Years
Habit Doubles Up for National Burger Day with a Week of 2-for-1 Charburgers
Appian Corporation to Present in Upcoming Investor Conferences
Go Brands Expands Portfolio to Advance Light Cannabis Category
Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions
Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World of Culture Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.